| |
| | Drug-drug interactions of antivirals, immunosuppressants and immunizations |
 | | Antiviral and immunosuppressant drugs are being used increasingly more often in children, and because many of these drugs interact with many other commonly used drugs, it is imperative that clinicians become familiar with these interactions, and their clinical significance. |
 | | Drugs commonly used in the pediatric population whose hepatic metabolism may be inhibited include benzodiazepines (e.g., midazolam), opiate analgesics, cisapride, astemizole, and glucocorticoids. |
 | | Drugs that may induce the hepatic metabolism of the antiretrovirals (and thus potentially reduce their efficacy) include rifampin (Rifadin, Rifamate, Rifater, Hoechst Marion Roussel) and rifabutin (Mycobutin, Pharmacia and Upjohn), various anticonvulsants (e.g., phenobarbital, phenytoin [Dilantin, Parke-Davis], carbamazepine), and dexamethasone. |
| www.infectiousdiseasenews.com /200001/drug.asp (1223 words) |
|